Details for Patent: 7,829,574
✉ Email this page to a colleague
Which drugs does patent 7,829,574 protect, and when does it expire?
Patent 7,829,574 protects FRUZAQLA and is included in one NDA.
This patent has twenty-eight patent family members in twenty countries.
Drugs Protected by US Patent 7,829,574
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | FRUZAQLA | fruquintinib | CAPSULE;ORAL | 217564-001 | Nov 8, 2023 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Takeda Pharms Usa | FRUZAQLA | fruquintinib | CAPSULE;ORAL | 217564-002 | Nov 8, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,829,574
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009244130 | ⤷ Sign Up | |||
| Brazil | PI0908675 | ⤷ Sign Up | |||
| Canada | 2723148 | ⤷ Sign Up | |||
| Cyprus | 1117222 | ⤷ Sign Up | |||
| Denmark | 2297115 | ⤷ Sign Up | |||
| European Patent Office | 2297115 | ⤷ Sign Up | |||
| Spain | 2550245 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
